|
1
|
Maximov VV and Aqeilan RI: Genetic factors
conferring metastasis in osteosarcoma. Future Oncol. 12:1623–1644.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang J, Yu XH, Yan YG, Wang C and Wang
WJ: PI3K/Akt signaling in osteosarcoma. Clin Chim Acta.
444:182–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mannavola F, Tucci M, Felici C, Stucci S
and Silvestris F: miRNAs in melanoma: A defined role in tumor
progression and metastasis. Expert Rev Clin Immunol. 12:79–89.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bostjancic E and Glavac D: Importance of
microRNAs in skin morphogenesis and diseases. Acta Dermatovenerol
Alp Pannonica Adriat. 17:95–102. 2008.PubMed/NCBI
|
|
11
|
Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ,
Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG and Bae DS: Altered
MicroRNA expression in cervical carcinomas. Clin Cancer Res.
14:2535–2542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Negrini M and Calin GA: Breast cancer
metastasis: A microRNA story. Breast Cancer Res. 10:2032008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thompson LD: Osteosarcoma. Ear Nose Throat
J. 92:288–290. 2013.PubMed/NCBI
|
|
14
|
Xu H, Mei Q, Xiong C and Zhao J:
Tumor-suppressing effects of miR-141 in human osteosarcoma. Cell
Biochem Biophys. 69:319–325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bassampour SA, Abdi R, Bahador R, Shakeri
M, Torkaman A, Yahaghi E and Taheriazam A: RETRACTED ARTICLE:
Downregulation of miR-133b/miR-503 acts as efficient prognostic and
diagnostic factors in patients with osteosarcoma and these
predictor biomarkers are correlated with overall survival. Tumour
Biol. Aug 16–2015.(Epub ahead of print). PubMed/NCBI
|
|
16
|
Duan Z, Choy E, Harmon D, Liu X, Susa M,
Mankin H and Hornicek F: MicroRNA-199a-3p is downregulated in human
osteosarcoma and regulates cell proliferation and migration. Mol
Cancer Ther. 10:1337–1345. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song H, Zhang Y, Liu N, Wan C, Zhang D,
Zhao S, Kong Y and Yuan L: miR-92b regulates glioma cells
proliferation, migration, invasion, and apoptosis via PTEN/Akt
signaling pathway. J Physiol Biochem. 72:201–211. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma G, Jing C, Li L, Huang F, Ding F, Wang
B, Lin D, Luo A and Liu Z: MicroRNA-92b represses
invasion-metastasis cascade of esophageal squamous cell carcinoma.
Oncotarget. 7:20209–20222. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou Z, Wang Z, Wei H, Wu S, Wang X and
Xiao J: Promotion of tumour proliferation, migration and invasion
by miR-92b in targeting RECK in osteosarcoma. Clin Sci (Lond).
130:921–930. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Soltani S, Mokarian F and Panjehpour M:
The expression of CK-19 gene in circulating tumor cells of blood
samples of metastatic breast cancer women. Res Pharm Sci.
10:485–496. 2015.PubMed/NCBI
|
|
21
|
Li Y, Li L, Guan Y, Liu X, Meng Q and Guo
Q: MiR-92b regulates the cell growth, cisplatin chemosensitivity of
U2OS non small cell lung cancer cell line and target PTEN. Biochem
Biophys Res Commun. 440:604–610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lei L, Huang Y and Gong W: Inhibition of
miR-92b suppresses nonsmall cell lung cancer cells growth and
motility by targeting RECK. Mol Cell Biochem. 387:171–176. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu ZB, Cai L, Lin SJ, Lu JL, Yao Y and
Zhou LF: The miR-92b functions as a potential oncogene by targeting
on Smad3 in glioblastomas. Brain Res. 1529:16–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Niehrs C: Function and biological roles of
the Dickkopf family of Wnt modulators. Oncogene. 25:7469–7481.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fukusumi Y, Meier F, Götz S, Matheus F,
Irmler M, Beckervordersandforth R, Faus-Kessler T, Minina E, Rauser
B, Zhang J, et al: Dickkopf 3 promotes the differentiation of a
rostrolateral midbrain dopaminergic neuronal subset in vivo and
from pluripotent stem cells in vitro in the mouse. J Neurosci.
35:13385–13401. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Lin L, Thomas DG, Nadal E, Chang
AC, Beer DG and Lin J: The role of Dickkopf-3 overexpression in
esophageal adenocarcinoma. J Thorac Cardiovasc Surg.
150:377–385.e2. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ryu SW, Kim JH, Kim MK, Lee YJ, Park JS,
Park HM, Kim DH, Lee SH and Lee EJ: Reduced expression of DKK3 is
associated with adverse clinical outcomes of uterine cervical
squamous cell carcinoma. Int J Gynecol Cancer. 23:134–140. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park
J, Chae M, Zhang W and Lee JH: Dkk3, downregulated in cervical
cancer, functions as a negative regulator of beta-catenin. Int J
Cancer. 124:287–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Q, Shen K, Zhao Y, Ma C, Liu J and Ma
J: MiR-92b inhibitor promoted glioma cell apoptosis via targeting
DKK3 and blocking the Wnt/beta-catenin signaling pathway. J Transl
Med. 11:3022013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hoang BH, Kubo T, Healey JH, Yang R,
Nathan SS, Kolb EA, Mazza B, Meyers PA and Gorlick R: Dickkopf 3
inhibits invasion and motility of Saos-2 osteosarcoma cells by
modulating the Wnt-beta-catenin pathway. Cancer Res. 64:2734–2739.
2004. View Article : Google Scholar : PubMed/NCBI
|
